Decreased connexin 43 and increased fibrosis in atrial regions susceptible to complex fractionated atrial electrograms

Cardiology

Volumn 114, Issue 1, 2009, Pages 22-29

  Liu, Xu ^a   Shi, Hai Feng ^a   Tan, Hong Wei ^a   Wang, Xin Hua ^a   Zhou, Li ^a   Gu, Jia Ning ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Atrial fibrillation; Complex fractionated atrial electrograms; Connexin 43

Indexed keywords

CONNEXIN 43;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATHETER ABLATION; COMPLEX FRACTIONATED ATRIAL ELECTOGRAM; CONTROLLED STUDY; ELECTROGRAPHY; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART MUSCLE FIBROSIS; HISTOPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWINE; TISSUE DISTRIBUTION;

ANIMALS; ATRIAL FIBRILLATION; CONNEXIN 43; DISEASE MODELS, ANIMAL; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; FIBROSIS; HEART ATRIA; IMMUNOHISTOCHEMISTRY; MALE; MYOCARDIUM; SWINE;

EID: 63349105258     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000210398     Document Type: Article

References (30)

1. Oral H, Knight BP, Tada H, Ozaydin M, Chugh A, Hassan S, Scharf C, Lai SW, Green-stein R, Pelosi F Jr, Strickberger SA, Morady F: Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation 2002;105:1077-1081.
2. Liu X, Wang XH, Gu JN, Zhou L, Qiu JH: Electroanatomical systems to guided circumferential pulmonary veins ablation for atrial fibrillation: initial experience from comparison between the Ensite/NavX and CARTO system. Chin Med J (Engl) 2005;118: 1156-1160.
3. Nademanee K, McKenzie J, Kosar E, Schwab M, Sunsaneewitayakul B, Vasavakul T, Khunnawat C, Ngarmukos T: A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol 2004;43:2044-2053.
4. Nademanee K, Schwab MC, Kosar EM, Karwecki M, Moran MD, Visessook N, Michael AD, Ngarmukos T: Clinical outcomes of catheter substrate ablation for high-risk patients with atrial fibrillation. J Am Coll Cardiol 2008;51:843-849.
5. Schmitt C, Estner H, Hecher B, Luik A, Kolb C, Karch M, Ndrepepa G, Zrenner B, Hessling G, Deisenhofer I: Radiofrequency ablation of complex fractionated atrial electro-grams (CFAE): preferential sites of acute termination and regularization in paroxysmal and persistent atrial fibrillation. J Car-diovasc Electrophysiol 2007;18:1039-1046.
6. Oral H, Chugh A, Good E, Wimmer A, Dey S, Gadeela N, Sankaran S, Crawford T, Sar-razin JF, Kuhne M, Chalfoun N, Wells D, Frederick M, Fortino J, Benloucif-Moore S, Jongnarangsin K, Pelosi F Jr, Bogun F, Morady F: Radiofrequency catheter ablation of chronic atrial fibrillation guided by complex electrograms. Circulation 2007;115: 2606-2612.
7. Spach MS, Starmer CF: Altering the topology of gap junctions a major therapeutic target for atrial fibrillation. Cardiovasc Res 1995;30:337-344.
8. Burstein B, Nattel S: Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 2008;51:802-809.
9. Severs NJ, Bruce AF, Dupont E, Rothery S: Remodelling of gap junctions and connexin expression in diseased myocardium. Car-diovasc Res 2008;80:9-19.
10. Vozzi C, Dupont E, Coppen SR, Yeh HI, Severs NJ: Chamber-related differences in con-nexin expression in the human heart. J Mol Cell Cardiol 1999;31:991-1003.
11. Yeh HI, Lai YJ, Lee SH, Lee YN, Ko YS, Chen SA, Severs NJ, Tsai CH: Heterogeneity of myocardial sleeve morphology and gap junctions in canine superior vena cava. Circulation 2001;104:3152-3157.
12. Luo MH, Li YS, Yang KP: Fibrosis of collagen I and remodeling of connexin 43 in atri-al myocardium of patients with atrial fibrillation. Cardiology 2007;107:248-253.
13. Wang XH, Liu X, Sun YM, Gu JN, Shi HF, Zhou L, Hu W: Earlyidentification and treatment of PV re-connections: role of observation time and impact on clinical results of atrial fibrillation ablation. Europace 2007;9: 481-486.
14. Lin J, Scherlag BJ, Zhou J, Lu Z, Patterson E, Jackman WM, Lazzara R, Po SS: Autonomic mechanism to explain complex fractionated atrial electrograms (CFAE). J Cardiovasc Electrophysiol 2007;18:1197-1205.
15. Wu J, Estner H, Luik A, Ucer E, Reents T, Pflaumer A, Zrenner B, Hessling G, Deisen-hofer I: Automatic 3D mapping of complex fractionated atrial electrograms (CFAE) in patients w it h parox y smal a nd persistent atr i-al fibrillation. J Cardiovasc Electrophysiol 2008;19:897-903.
16. Tan HW, Xing SS, Bi XP, Li L, Gong HP, Zhong M, Zhang Y, Zhang W: Felodipine attenuates vascular inflammation in a fructose-induced rat model of metabolic syndrome via the inhibition of NF-κBactivation. Acta Pharmacol Sin 2008;29:1051-1059.
17. Kasperkovitz PV, Verbeet NL, Smeets TJ, van Rietschoten JG, Kraan MC, van der Pouw Kraan TC, Tak PP, Verweij CL: Activation of the STAT1 pathway in rheumatoid arthritis. Ann Rheum Dis 2004;63:233-239.
18. Xing SS, Tan HW, Bi XP, Zhong M, Zhang Y, Zhang W: Felodipine reduces cardicac expression of IL-18 and perivascular fibrosis in fructose-fed rats. Mol Med 2008;14:395-402.
19. Haïssaguerre M, Sanders P, Hocini M, Hsu LF, Shah DC, Scavée C, Takahashi Y, Rotter M, Pasquié JL, Garrigue S, Clémenty J, Jaïs P: Changes in atrial fibrillation cycle length and inducibility during catheter ablation and their relation to outcome. Circulation 2004;109:3007-3013.
20. Estner HL, Hessling G, Ndrepepa G, Luik A, Schmitt C, Konietzko A, Ucer E, Wu J, Kolb C, Pflaumer A, Zrenner B, Deisenhofer I: Acute effects and long-term outcome of pulmonary vein isolation in combination with electrogram-guided substrate ablation for persistent atrial fibrillation. Am J Cardiol 2008;101:332-337.
21. Konings KT, Smeets JL, Penn OC, Wellens HJ, Allessie MA: Configuration of unipolar atrial electrograms during electrically induced atrial fibrillation in humans. Circulation 1997;95:1231-1241.
22. Rostock T, Rotter M, Sanders P, Takahashi Y, Jaïs P, Hocini M, Hsu LF, Sacher F, Clémenty J, Haïssaguerre M: High-density activation mapping of fractionated electrograms in the atria of patients with paroxysmal atrial fibrillation. Heart Rhythm 2006;3:27-34.
23. Lu Z, Scherlag BJ, Lin J, Niu G, Ghias M, Jackman WM, Lazzara R, Jiang H, Po SS: Au-tonomic mechanism for complex fractionated atrial electrograms: evidence by fast fourier transform analysis. J Cardiovasc Electrophysiol 2008;19:835-842.
24. Hocini M, Ho SY, Kawara T, Linnenbank AC, Potse M, Shah D, Jaïs P, Janse MJ, Haïs-saguerre M, De Bakker JM: Electrical conduction in canine pulmonary veins: electrophysiological and anatomic correlation. Circu lation 20 02;10 5:2442-2448.
25. Jalife J, Morley GE, Vaidya D: Connexins and impulse propagation in the mouse heart. J Cardiovasc Electrophysiol 1999;10:1649-1663.
26. Elvan A, Huang XD, Pressler ML, Zipes DP: Radiofrequency catheter ablation of the atria eliminates pacing-induced sustained atrial fibrillation and reduces connexin 43 in dogs. Circulation 1997;96:1675-1685.
27. Polontchouk L, Haefliger JA, Ebelt B, Schaefer T, Stuhlmann D, Mehlhorn U, KuhnRegnier F, De Vivie ER, Dhein S: Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria. J Am Coll Cardiol 2001;38:883-891.
28. Sun Q, Tang M, Pu J, Zhang S: Pulmonary venous structural remodeling in a canine model of chronic atrial dilation due to mitral regurgitation. Can J Cardiol 2008;24:305-308.
29. Guerra JM, Everett TH 4th, Lee KW, Wilson E, Olgin JE: Effects of the gap junction modifier rotigaptide (ZP123) on atrial conduction and vulnerability to atrial fibrillation. Circulation 2006;114:110-118.
30. Shiroshita-Takeshita A, Sakabe M, Haugan K, Hennan JK, Nattel S: Model-dependent effects of the gap junction conduction-enhancing antiarrhythmic peptide rotigaptide (ZP123) on experimental atrial fibrillation in dogs. Circulation 2007;115:310-318.